​

Penumbra (PEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PEN Stock Forecast

Penumbra (PEN) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $232.09, with a high of $275.00 and a low of $178.00. This represents a -13.95% decline from the last price of $269.73.

$150 $180 $210 $240 $270 $300 High: $275 Avg: $232.09 Low: $178 Last Closed Price: $269.73

PEN Stock Rating

Penumbra stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (57.14%), 6 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 6 8 Strong Sell Sell Hold Buy Strong Buy

PEN Forecast vs Benchmarks

TypeNameUpside
StockPenumbra-13.95%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts-317
Avg Price Target-$250.33$221.76
Last Closing Price$269.73$269.73$269.73
Upside/Downside--7.19%-17.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 252124--18
Dec, 243115--19
Nov, 24395--17
Oct, 24697--22
Sep, 24697--22
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 11, 2024Larry BiegelsenWells Fargo$275.00$253.668.41%1.95%
Oct 31, 2024Matt O'BrienPiper Sandler$235.00$211.2911.22%-12.88%
Oct 31, 2024Pito ChickeringDeutsche Bank$241.00$211.2914.06%-10.65%
Oct 18, 2024Matt O'BrienPiper Sandler$225.00$202.2611.24%-16.58%
Oct 16, 2024Jason MillsCanaccord Genuity$235.00$206.6213.74%-12.88%
Oct 15, 2024David RescottRobert W. Baird$244.00$211.3615.44%-9.54%
Oct 14, 2024Richard NewitterTruist Financial$235.00$214.929.34%-12.88%
Oct 08, 2024Shagun SinghRBC Capital$222.00$190.8116.35%-17.70%
Sep 17, 2024Matthew BlackmanStifel Nicolaus$238.00$187.0627.23%-11.76%
Sep 03, 2024Mike KratkyLeerink Partners$263.00$202.3229.99%-2.50%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024Wells FargoEqual-WeightOverweightupgrade
Oct 31, 2024RBC CapitalOutperformOutperformhold
Oct 31, 2024Deutsche BankBuyBuyhold
Oct 18, 2024Piper SandlerOverweightOverweighthold
Oct 16, 2024Canaccord GenuityBuyBuyhold
Oct 15, 2024Wells FargoEqual-WeightEqual-Weighthold
Oct 14, 2024BTIGBuyBuyhold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Aug 28, 2024BTIGBuyBuyhold
Aug 22, 2024CitigroupNeutralNeutralhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 $7 $8 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.54$0.07$-0.05$2.37-----
Avg Forecast$-0.18$0.81$0.15$2.03$2.79$3.80$4.96$6.32$7.56
High Forecast$-0.18$0.80$0.15$1.90$2.68$3.49$4.46$5.76$7.35
Low Forecast$-0.17$0.83$0.16$2.20$2.97$4.37$5.83$6.87$7.72
Surprise %200.00%-91.36%-133.33%16.75%-----

Revenue Forecast

$500M $900M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$560.41M$747.59M$847.13M$1.06B-----
Avg Forecast$548.91M$738.09M$843.69M$1.06B$1.19B$1.36B$1.56B$1.76B$1.98B
High Forecast$541.38M$727.97M$829.90M$1.04B$1.17B$1.34B$1.56B$1.75B$1.93B
Low Forecast$560.31M$753.42M$854.36M$1.08B$1.20B$1.38B$1.56B$1.77B$2.01B
Surprise %2.10%1.29%0.41%-0.20%-----

Net Income Forecast

$-50M $30M $110M $190M $270M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-19.26M$2.62M$-2.00M$90.95M-----
Avg Forecast$-8.11M$-4.05M$-34.15M$90.95M$110.92M$146.01M$192.40M$260.55M$296.48M
High Forecast$-21.10M$-16.95M$-45.49M$61.17M$105.26M$136.95M$175.08M$226.04M$288.28M
Low Forecast$4.89M$8.84M$-22.81M$120.73M$116.57M$171.28M$228.83M$269.26M$302.75M
Surprise %137.52%-164.72%-94.14%------

PEN Forecast FAQ

Is Penumbra stock a buy?

Penumbra stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Penumbra is a favorable investment for most analysts.

What is Penumbra's price target?

Penumbra's price target, set by 14 Wall Street analysts, averages $232.09 over the next 12 months. The price target range spans from $178 at the low end to $275 at the high end, suggesting a potential -13.95% change from the previous close price of $269.73.

How does Penumbra stock forecast compare to the average forecast of its sector, industry, and investment themes?

Penumbra stock forecast shows a -13.95% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for Penumbra over the past three months?

  • January 2025: 11.11% Strong Buy, 66.67% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 15.79% Strong Buy, 57.89% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 17.65% Strong Buy, 52.94% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.

What is Penumbra’s EPS forecast?

Penumbra's average annual EPS forecast for its fiscal year ending in December is 2.79 for 2024, a 17.72% increase from the reported $2.37 in 2023. The prediction for 2025 is $3.8, $4.96 for 2026, $6.32 for 2027, and $7.56 for 2028.

What is Penumbra’s revenue forecast?

Penumbra's average annual revenue forecast for its fiscal year ending in December is $1.19B for 2024, a 12.48% increase from the reported $1.06B in 2023. The forecast for 2025 is $1.36B, $1.56B for 2026, $1.76B for 2027, and $1.98B for 2028.

What is Penumbra’s net income forecast?

For its fiscal year ending in December, Penumbra's average annual net income forecast is $110.92M for 2024, reflecting an 21.95% increase from the reported $90.95M in 2023. The projection for 2025 is $146.01M, $192.4M for 2026, $260.55M for 2027, and $296.48M for 2028.